Observational Study to Deeply Phenotype Major Organs in Sickle Cell Disease After Curative Therapies

Conditions:   Mortality in Sickle Cell;   Sickle Cell Cardiopulmonary Complications;   Sickle Cell Organ Damage;   Sickle Cell Life Expectancy and Risk Factors for Early Death;   Sickle Cell Lung Disease and Sudden Death Intervention:   Sponsor:   National Heart, Lung, and Blood Institute (NHLBI) Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials